介入法取出断入上腔静脉及右心腔中心静脉导管二例

例1 患者男性,13岁,因"发现脊柱畸形1个月余"于2009年8月7日入院.入院查体:脉搏100次/min,血压110/70 mm Hg(1 mm Hg=0.133 kPa).心尖搏动位于第5肋间左锁骨中线内0.5 cm处,心前区未触及震颤,心浊音界正常,心率100次/min,心律整齐,第1心音正常,A2>P2,胸骨左缘3、4肋间可闻及2/6收缩期吹风样杂音.诊断为胸椎发育畸形并脊柱侧弯.心电图示窦性心动过速,电轴右偏+127°.     

Superior vena cava thrombosis in chronic lead exposure--a case report

Thrombosis is a rare cause of superior vena cava syndrome (SVCS). A 43-year-old male patient with SVCS due to thrombosis underwent investigation for the etiology of thrombus formation. He had been hospitalized several times because of lead intoxication in the past. Lead has a known thrombogenetic effect experimentally. This patient with superior vena cava thrombosis had thrombophilia that was probably due to lead intoxication. The etiologies of venous thrombosis and thrombogenetic effect of chronic lead exposure are discussed.     

老年变异型心绞痛2例

1临床资料 患者1,男性,72岁,因“间断心前区疼痛1年,加重12h”,于2010年6月26日以“急性冠脉综合征”入院。患者无明显诱因反复出现心前区疼痛1年,每次持续3min左右,含服“硝酸甘油”后缓解,多于凌晨4：00～5：00时发作。入院前12h反复发作10余次,含服“硝酸甘油”约3min缓解。既往有高血压病史2年,血压控制尚可。吸烟40余年,平均20支／d。无糖尿病、冠心病家族史。查体：     

Superior vena cava syndrome in children

Superior vena cava syndrome (SVCS) is rare in childhood. 18 cases of SVCS were seen in children ranging from 3–14 years with a mean age of 8.8 years. There were 15 males and 3 female children. Diagnosis could be confirmed in 17 cases as one child succumbed to severe respiratory distress without a definitive diagnosis. The commonest cause of SVCS was lymphoma. Non-Hodgkin’s lymphoma (NHL) was more common than Hodgkin’s disease. In two cases the final diagnosis was tuberculosis of mediastinal lymph nodes. The diagnosis was confirmed by cervical lymph node biopsy in 6 cases, mediastinal biopsy in 6 cases and bone marrow aspiration in the remaining 5 cases. Intravenous Dexamethasone provided relief of symptoms in 13 patients. None of the children received emergency radiotherapy. Anti-tubercular treatment produced complete cure in the two patients with tubercular mediastinal lymphadenopathy.     

Superior vena cava syndrome: diagnostic procedures

The hospital records of patients discharged from Presbyterian-University Hospital of Pittsburgh with the diagnosis of superior vena cava syndrome (SVCS) were reviewed in order to determine if diagnostic procedures were associated with an unacceptable risk of complications. Fifty-six cases were reviewed. Symptoms had been present for an average of five weeks. Forty-five patients underwent diagnostic tests including sputum cytology, lymph node biopsy, bone marrow biopsy, bronchoscopy, mediastinoscopy and thoracotomy. The diagnostic yield of these procedures ranged from 28% (cytology) to 100% (thoracotomy). Complications occurred only with mediastinoscopy and none of these were fatal or caused long-term morbidity. We conclude that most patients with SVCS (excepting those with neurologic or respiratory compromise) can tolerate a vigorous pursuit of a histologic diagnosis before therapy is instituted.     

Superior vena cava syndrome: a rare complication of saphenous vein graft stenting: a case report

Rupture of coronary artery bypass graft during percutaneous coronary intervention is a rare but serious complication. These perforations are often associated with myocardial infarction, pericardial tamponade, immediate or delayed, emergency bypass surgery and even death. We report an interesting case where perforation of a saphenous vein graft occurred after direct stenting, resulting in a very rare complication of superior vena cava (SVC) syndrome.     

Superior vena cava thrombosis in a patient on hemodialysis

We present a patient with end-stage renal disease on maintenace hemodialysis through a permanent catheter (Permcath) on the right subclavian vein. One month after the catheter placement the patient exhibited a superior vena cava syndrome due to a pericatheter thrombosis. The patient was initially managed with anticoagulation with early clinical improvement. Nevertheless, the reappearance of the symptoms forced the removal of the catheter and percutaneous angioplasty of the superior vena cava. After those measures and anticoagulation with coumarin the patient remains stable with complete clinical resolution and angiographical improvement.     

Superior vena cava syndrome after bone marrow transplantation caused by aspergillosis: a case report

Aspergillosis is known for the variety of unusual presentations in immuno-suppressed patients. We report a patient in whom aspergillosis caused the superior vena cava (SVC) syndrome. A 37-year-old woman became febrile soon after bone marrow transplantation (BMT). Chest radiography demonstrated a 5-cm mass extending from the right lung apex to the right supraclavicular fossa beside her Hickman catheter. She then developed SVC syndrome, which progressed despite treatment. Despite recovery of the white blood cell count, the patient continued to deteriorate, became comatose, suffered a cardiac arrest and died 31 days after BMT. Autopsy revealed Aspergillus infection at the apex of the right lung associated with innominate artery thrombosis.     

Superior vena cava flutter: electrophysiology and ablation

INTRODUCTION: Reentry within a major thoracic vein has been suggested as a cause of atrial arrhythmias. However, little is known about these potential reentrant circuits. METHODS AND RESULTS: Atypical atrial flutter was induced and mapped in 67 out of 225 atrial flutter ablation procedures. Reentry around the superior vena cava (SVC) was suspected in three patients. The suspected SVC flutter was induced and terminated by pacing in all patients. Fusion was demonstrated during flutter entrainment by subeustachian isthmus pacing in all of them. The postpacing interval following entrainment by pacing from different sites of the right atrium (RA) or coronary sinus was longer than the flutter cycle length. Macroreentry within the SVC was demonstrated both by sequential activation and a postpacing interval matching the flutter cycle length when pacing from different sites around the SVC in all patients. Atrial-venous-atrial electrogram sequence was demonstrated following flutter entrainment by atrial pacing. Flutter was terminated by an electrical stimulus delivered to the SVC, which was not propagated to the trabeculated RA, in one patient, and linear radiofrequency application from the distal SVC to the posterior wall of the RA, or to the superoseptal portion of the crista terminalis, in the other two. CONCLUSION: Macroreentry within the SVC is a distinctive mechanism responsible for rapid atrial activation, which is different from other reported flutter mechanisms, such as upper loop reentry. SVC longitudinal radiofrequency application can eliminate the arrhythmia without the need for complete electrical disconnection of the vein.     

Superior vena cava syndrome caused by a malignant tumor: a retrospective single-center analysis of 124 cases

Purpose

Superior vena cava syndrome (SVCS) results from compression of the superior vena cava. SVCS is an emergency requiring immediate diagnosis and treatment. We hypothesized that the outcome of patients (pts.) admitted during regular work hours may differ from that of pts. admitted on weekends.

Methods

From 1992 to 2011, we analyzed all pts. admitted with SVCS due to a malignancy. Clinical outcome was analyzed, focusing on the work-up of pts. hospitalized on a weekend compared with those hospitalized during the week.

Results

One hundred and twenty-four pts. with malignant causes of SVCS were analyzed. Causes were as follows: small cell lung cancer (SCLC) 28.2 %, non-small cell lung cancer 25 %, non-Hodgkin’s lymphoma 25 %, metastasis of other malignant tumors 19.4 % and Hodgkin’s disease 2.4 %. Sixty-five percent of pts. were admitted during the week and 35 % on a weekend. Sixty-one percent received chemotherapy, 24 % radiation, 4 % radiochemotherapy, 9 % palliative treatment and 2 % no treatment at all. No difference in choice of treatment between pts. admitted on a weekday versus weekend was seen. Response was as follows: 7 pts. complete remission, 20 pts. partial response, 38 pts. progressive disease, 3 pts. NC and 15 pts. died. Overall response rate was as follows: Hodgkin’s disease 100 %, non-Hodgkin’s lymphoma 29 %, SCLC 22.8 %, non-small cell lung cancer 9.6 % and metastatic cancer 16.6 %. Only 2 of the 34 pts. with relapsing carcinoma responded. None of the pts. died due to SVCS.

Conclusion

The outcome of pts. with SVCS is not dependent on the day of admission (weekend or weekday) but is related to underlying disease in the setting of a tertiary care center.     

Superior vena cava stenosis at site of intersection of two pacing electrodes

Superior vena cava obstruction is described in a patient with two endocardial pacing electrodes. At necropsy a severe stenosis of the venous lumen was found at the site of intersection of the two catheters. There was no evidence of thrombus formation. Venous wall stenosis is an unusual complication of transvenous pacing and is probably favoured by the presence of two electrodes.     

Transitional cell carcinoma of the renal pelvis with extension into the inferior vena cava: a report of two cases

Of all primary malignant renal tumors, 10% to 15% originate from the renal pelvis, and 90% to 92% of these tumors are transitional cell carcinomas. Nonetheless, renal pelvis transitional cell carcinoma extending into the inferior vena cava is very rare. We report one confirmed case and one highly suspicious case of renal pelvis transitional cell carcinoma with a tumor thrombus in the inferior vena cava. Both of our patients died within 6 months of initial diagnosis, indicating the poor prognosis and advanced stage of transitional cell carcinoma with an inferior vena cava thrombus. Transitional cell carcinoma should be considered in patients with obstruction of the renal vein and the inferior vena cava.     

Superior vena cava stenosis at site of intersection of two pacing electrodes.

Superior vena cava obstruction is described in a patient with two endocardial pacing electrodes. At necropsy a severe stenosis of the venous lumen was found at the site of intersection of the two catheters. There was no evidence of thrombus formation. Venous wall stenosis is an unusual complication of transvenous pacing and is probably favoured by the presence of two electrodes.     

Superior vena cava syndrome as a complication of colon carcinoma

Superior vena cava syndrome is a group of signs and symptoms resulting from the impairment of blood flow through the SVC into the right atrium. We present a case of a 54-year-old female with superior vena cava syndrome due to metastasis of colon carcinoma into the SVC leading to an intraluminal obstruction. To our knowledge this is the first published report of an intraluminal metastasis of colon adenocarcinoma into the superior vena cava causing SVC syndrome.     

Leiomyosarcoma of the inferior vena cava: a case report

Leiomyosarcoma of the inferior vena cava is an extremely rare tumor that is characterized by a poor prognosis and nonspecific symptoms, a fact that may delay the diagnosis for several years. The only therapeutic modality proven to prolong the survival of patients is total surgical resection of the tumor. In this study, the authors report the case of a 50-year-old patient with a diagnosis of leiomyosarcoma of the inferior vena cava, affecting the middle and distal thirds, who was submitted to surgical treatment.     

Superior vena cava syndrome early after pacemaker implantation in a patient with lung carcinoma: A case report

Superior vena cava (SVC) syndrome is typically dramatic. Although the diagnosis is usually easy, elucidation of the etiology is difficult. We present a patient who developed SVC syndrome early after transvenous pacemaker implantation and who was subsequently diagnosed with lung carcinoma. The pathogenesis seems to be explained by a combination of two etiologies: lung carcinoma plus transvenous pacemaker implantation. We emphasize that common etiologies such as malignancy should be considered first when faced with SVC syndrome.